- Info
- Significant Ownership
Significant Ownership of AbbVie Biotechnology Ltd
- Signature - Title
- /s/ Arthur C. Price - Arthur C. Price/Director
- Location
- Hamilton
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by AbbVie Biotechnology Ltd.
Follow Filing Activity
Follow AbbVie Biotechnology Ltd and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of AbbVie Biotechnology Ltd
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CARM | Carisma Therapeutics Inc. | Common Stock, $0.001 par value | 4.4% | $408,292 | 1,855,871 | AbbVie Biotechnology Ltd. | 31 Mar 2025 |
Schedules 13D/G Reported by AbbVie Biotechnology Ltd:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.